Effects of Total Cumulative and Early vs Late Dose Reductions in FEC-D for Early Stage Breast Cancer
In this retrospective study, researchers sought to determine the survival impact of reductions in total cumulative dose and early vs late dose reductions of third-generation adjuvant chemotherapy regimens in patients with early-stage breast cancer.
